The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement.

Jan Mizera Marketa Sovova Samuel Genzor Ladislav Stanke Radim Burget Petr Jakubec Martin Vykopal Pavol Pobeha Jana Zapletalova

Published in: Pneumonia (Nathan Qld.) (2024)

Better improvement of pulmonary function, radiological findings and subjective symptoms were observed in patients CS compared to watchful waiting. Our findings suggest that glucocorticoid therapy could benefit selected patients with persistent dyspnea, significant radiological changes, and decreased DLCO.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
sars cov
chronic kidney disease
randomized controlled trial
systematic review
pulmonary hypertension
prognostic factors
peritoneal dialysis
sleep quality
stem cells
patient reported